T1	intervention 376 397	real acupuncture (RA)
T2	control 413 434	sham acupuncture (SA)
T3	eligibility 515 649	Postmenopausal women with a stage 0 through III breast cancer who received an AI and had treatment-associated musculoskeletal symptoms
T4	duration 677 685	8 weekly
T5	outcome-Measure 750 843	National Surgical Adjuvant Breast and Bowel Project (NSABP) menopausal symptoms questionnaire
T6	outcome-Measure 849 907	Center for Epidemiological Studies Depression (CESD) scale
T7	outcome-Measure 1006 1027	hot flash daily diary
T8	outcome-Measure 1033 1083	Hot Flash-Related Daily Interference Scale (HFRDI)
T9	outcome-Measure 1093 1134	European quality-of-life survey (EuroQol)
T10	intervention-participants 1251 1253	23
T11	control-participants 1281 1283	24
T12	outcome 1420 1426	scores
T13	outcome 1481 1485	CESD
T14	outcome 1498 1516	hot flash severity
T15	outcome 1529 1548	hot flash frequency
T16	outcome 1565 1570	HFRDI
T17	outcome 1587 1612	NSABP menopausal symptoms
T18	outcome 1676 1683	EuroQol
T19	outcome 1699 1704	HFRDI
T20	outcome 1721 1746	NSABP menopausal symptoms
T21	ethinicity 1792 1808	African American
T22	ethinicity 1871 1891	non-African American
